Novel mutation of EPM2A causes progressive myoclonic epilepsy: a case report

Neurol Sci. 2022 May;43(5):3467-3471. doi: 10.1007/s10072-022-05986-0. Epub 2022 Mar 7.

Abstract

We report a case of progressive myoclonic epilepsy caused by a novel mutation in EPM2A. The female patient experienced abnormal jerky movements of the involving all four limbs and several generalized seizures, degeneration of cognition, and unsteadiness. Genetic analysis identified two rare, deleterious mutations in exon4: chr6: 145,948,751(c.G797G > A) and chr6: 145,948,761(c.T787C > T). The mutations at these two loci were from the genomes of their mother and father, respectively, which were compound heterozygous variations. This report updates the mutation sites of gene EPM2A and extends genotype-phenotype correlations in Lafora disease.

Keywords: Case; EPM2A; Epilepsy; Lafora disease; Seizure.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Lafora Disease* / genetics
  • Mutation / genetics
  • Myoclonic Epilepsies, Progressive* / genetics
  • Protein Tyrosine Phosphatases, Non-Receptor / genetics
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Ubiquitin-Protein Ligases
  • Protein Tyrosine Phosphatases, Non-Receptor
  • EPM2A protein, human